Dr. Kirk Kleinfeld is an Assistant Professor of Clinical Neurology at Vanderbilt University Medical Center. As a general neurologist, he evaluates and treats a wide array of neurological conditions primarily in the outpatient clinical setting in Franklin, TN. Dr. Kleinfeld is certified in both Neurology and Clinical Neurophysiology by the American Board of Psychiatry and Neurology, and is a member of the American Academy of Neurology.

Dr. Kleinfeld completed his internship and Neurology residency at VUMC, followed by a fellowship in Clinical Neurophysiology with a focus on EEG/evoked potentials and EMG/nerve conduction, also at Vanderbilt. Prior to his current position, he served as an attending physician at the Brain and Spine Center at St. Luke’s Hospital in Missouri. He completed his undergraduate coursework at the University of Evansville, and subsequently earned his Doctor of Medicine degree from the University of Tennessee Health Science Center.

Dr. Kerrigan practices both general and vascular neurology and is licensed to practice medicine in Tennessee and Kentucky. She has been a member of the American Board of Psychiatry and Neurology since 2018. In addition to her clinical practice at both the Vanderbilt University Medical Center and the Nashville VA Medical Center, Dr. Kerrigan is active with telemedicine. As an Assistant Professor of Medicine, Dr. Kerrigan is involved with medical student, resident, and fellow education.

Dr. Kerrigan earned a BS in both Elementary Education and Psychology concentrating in Neuroscience in 2006 from Vanderbilt University. She then performed medical research and completed a post-baccalaureate, pre-medical program, earning a MA in Biology from Washington University in St. Louis in 2010. She earned her MD from Saint Louis University School of Medicine in 2014 and then completed her Neurology residency and a Vascular Neurology fellowship at the Cleveland Clinic. She joined the faculty of Vanderbilt in August 2019.

Dr. Jing-Qiong (Katty) Kang is a professor specializing in epilepsy in the Vanderbilt University Department of Neurology. She is also a faculty member in the Vanderbilt Brain Institute, Vanderbilt Kennedy Center and Pharmacology at Vanderbilt University School of Medicine. 

Dr. Kang has been invited to present her work in multiple institutes and conferences nationally and internationally. Most recently, she has spoken at American Epilepsy Meeting (AES), Fukuoka University Medical School, Case Western Reserve University, Beijing Tiantan Neurosurgery Summit. She has been the chair for Basic Mechanisms and Neuroscience symposium at the AES meeting from 2015-2018. Dr. Kang is an award recipient of Citizens United for Research in Epilepsy (CURE), Dravet.org (formerly known as IDEA-League), Dravet syndrome foundation (DSF) and National Institute of Neurological Disorders and Stroke (NINDS). She is currently leading a large effort for developing treatment options for GABA transporter 1 encoding SLC6A1 mediated epilepsy and neurodevelopmental disorders.

Dr. Kang received her MD/PhD degree from Tongji Medical University, China. Prior to that, she worked at Tongji Hospital. She joined Dr. Kenneth Maiese in the Wayne State University Department of Neurology in August 2001 to study neurodegeneration before she joined Dr. Robert Macdonald’s lab at Vanderbilt University Medical Center in 2003. 

Dr. Angela L. Jefferson is a licensed clinical psychologist, Professor of Neurology, and Founding Director of the Vanderbilt Memory and Alzheimer’s Center at Vanderbilt University Medical Center. She is principal investigator of the Vanderbilt Memory and Aging Project, a longitudinal cohort study examining the complex intersection of vascular health and Alzheimer’s disease, and she is Director of the NIA-funded P20 Alzheimer’s Disease Research Center where she leads the Tennessee Alzheimer’s Project. Dr. Jefferson has extensive leadership and research experiences in the fields of cerebrovascular aging and Alzheimer’s disease. She serves as a member of the Alzheimer’s Association’s International Society to Advance Alzheimer’s Research and Treatment Advisory Council.

Dr. Jefferson has a long-standing commitment to professional education and training. She has held an NIA-funded K24 mentorship award since 2013, providing protected time to support the professional development of early career clinician scientists. She is the Director of the NIA-funded Vanderbilt Interdisciplinary Training Program in Alzheimer’s Disease (T32), and she is a member of the Scientific Advisory Committee for the prestigious Paul B. Beeson Emerging Leaders Career Development Program. 

David Isaacs is an Assistant Professor of Neurology at Vanderbilt University Medical Center with fellowship-training in movement disorders. Clinically, he is part of the VUMC Parkinson’s Disease Center of Excellence, Huntington’s Disease Center of Excellence, and Deep Brain Stimulation Clinic. In 2019, he founded the Vanderbilt Adult Tourette Syndrome Clinic to promote specialized clinical care and advance research initiatives in this patient population. In collaboration with Dr. Heather Riordan, he established the Vanderbilt Tourette Syndrome Working Group in 2020, a cross-disciplinary, trans-institutional consortium that meets monthly to review journal articles, discuss challenging clinical case, and develop research projects centered on Tourette syndrome. In 2021, he received the Vanderbilt Faculty Research Scholar Award, a career development award that will provide protected time and pilot funding to support his Tourette syndrome research.

Dr. Isaacs is a current member of the Movement Disorders Society and the Vanderbilt Kennedy Center. In 2015, he received both the Medical Student Teaching Award and the James Tru Martin Award for the Vanderbilt Department of Neurology. 

Dr. Isaacs earned his B.S. in Biophysics from the University of Southern Indiana and subsequently graduated from medical school at the Indiana University School of Medicine. He completed his neurology residency at Vanderbilt University Medical Center in 2015, serving as Chief Resident his final year. The following year he completed his Movement Disorders Fellowship at Vanderbilt before joining the faculty in 2016. In 2019, he earned his master’s degree in public health. 

Dr. Timothy Hohman is a Professor of Neurology, cognitive neuroscientist, and computational geneticist. Dr. Hohman’s research leverages advanced computational approaches from genomics, proteomics, and neuroscience to identify novel markers of Alzheimer’s disease risk and resilience. He leads the Biomarker Core for the Vanderbilt Memory & Alzheimer’s Center and holds leadership positions in multiple international consortia, including serving as the Contact-PI for the Alzheimer’s Disease Sequencing Project Phenotype Harmonization Consortium (ADSP-PHC; U24-AG074855) and directing the Genomics Core for the Preclinical Alzheimer’s Consortium.

Dr. Hohman received his BA in Psychology (magna cum laude) from Gordon College, followed by his MA in Psychology from American University. He received his doctoral degree in neuroscience from American University focusing on cognitive and neural changes during normal aging. He also completed a fellowship as part of the National Institutes of Health Graduate Partnership Program in the Laboratory of Behavioral Neuroscience at the National Institute on Aging.  He completed his postdoctoral training at Vanderbilt where he was a T32 postdoctoral research fellow as part of the Neurogenomics training program in 2012, a recipient of the Pharmaceutical Research and Manufacturers of America Foundation postdoctoral fellowship in translational medicine and therapeutics in 2013, and a K12 Building Interdisciplinary Research Careers in Women’s Health Scholar in 2015.Building Interdisciplinary Research Careers in Women’s Health Scholar in 2015. 

Amanda Hicklin is an Advanced Practice Nurse specializing in Neurology at Vanderbilt University Medical Center. As an outpatient nurse practitioner, she diagnoses and treats patients with a variety of sleep disorders. She is a member of the American Academy of Nurse Practitioners.

Prior to her current role at Vanderbilt, Amanda worked as a nurse practitioner in a variety of clinical settings. She also gained experience as an ECMO specialist at VUMC.

Amanda received an associate degree in respiratory sciences from Itawamba Community College. After working as a registered respiratory therapist for several years, she later earned her Master of Science in Nursing from Vanderbilt University. 

Dr. Travis Hassell is an Assistant Professor of Neurology specializing in Movement Disorders at Vanderbilt University Medical Center. His clinical practice and research focuses both on movement disorders and bioengineering, with an emphasis on developing new device technologies such as adaptive deep brain stimulation (DBS). Dr. Hassell also provides instruction in inpatient and outpatient clinical settings for medical students and residents. He is currently a member of the North American Neuromodulation Society, the Movement Disorders Society, the American Academy of Neurology, and the Biomedical Engineering Society (BMES). 

Prior to his current appointment, Dr. Hassell completed a Movement Disorders Fellowship at VUMC. He earned his MD from the Indiana University School of Medicine in 2012, and subsequently completed his medical internship at St. Elizabeth Medical Center (Youngstown, OH) and Neurology residency at Indiana University (Indianapolis, IN), serving as Chief Resident his final year. Dr. Hassell earned his doctorate in Biomedical Engineering from Purdue University (West Lafayette, IN), graduating summa cum laude with a thesis studying devices for real-time monitoring of central nervous system recovery. He received his BS in Biological Engineering (summa cum laude) from the University of Missouri – Columbia. 

Dr. Ye Han is a Research Associate Professor of Neurology at Vanderbilt University Medical Center, specializing in molecular/cellular mechanism studies of neurological disorders. Her research focuses on studying the structure and function of HCN channels and its auxiliary subunit, TRIP8b in the dorsal hippocampus and related neural circuitry with the hope of finding new therapies to treat neurological diseases. Dr. Han completed her PhD in molecular biology in the laboratory of Drs. Kang Chong and Zhihong Xu at the Chinese Academy of Sciences.